{
    "Trade/Device Name(s)": [
        "Emit II Plus Buprenorphine Assay",
        "Emit II Plus Specialty Drug Calibrator/Control Level 1",
        "Emit II Plus Specialty Drug Calibrator/Control Level 2",
        "Emit II Plus Specialty Drug Calibrator/Control Level 3",
        "Emit II Plus Specialty Drug Calibrator/Control Level 4",
        "Emit II Plus Specialty Drug Control Negative",
        "Emit II Plus Specialty Drug Control Positive"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K150606",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040316"
    ],
    "Regulatory Class": "II (Assay, Calibrator), I (Control)",
    "Product Code(s)": [
        "DJG",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "September 4, 2015",
    "Summary Letter Received Date": "September 8, 2015",
    "Submission Date": "October 20, 2015",
    "Regulation Number(s)": [
        "21CFR862.3650",
        "21CFR862.3200",
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Clinical Toxicology Calibrator",
        "Clinical Toxicology Control Material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        "Plastic bottle",
        "Plastic vial"
    ],
    "Instrument(s)/Platform(s)": [
        "Clinical chemistry analyzers",
        "Viva-E Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens Emit II Plus Buprenorphine Assay and specialty calibrators/controls for buprenorphine detection in urine using homogeneous enzyme immunoassay.",
    "Indications for Use Summary": "For qualitative and/or semiquantitative analysis of buprenorphine in human urine in laboratories, as a preliminary screening test; calibrators/controls are for calibration and quality control of the assay.",
    "fda_folder": "Toxicology"
}